| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Piomelli D | |
| Giuffrida A | |||
| P2860 | cites work | Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 |
| A second endogenous cannabinoid that modulates long-term potentiation | Q28248073 | ||
| Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist | Q28262546 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats | Q28332347 | ||
| Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice | Q28343324 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide | Q71743278 | ||
| Cannabis abuse and the course of recent-onset schizophrenic disorders | Q72371028 | ||
| Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization | Q72631582 | ||
| Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study | Q72656516 | ||
| Elevated endogenous cannabinoids in schizophrenia | Q73029596 | ||
| Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor | Q73704501 | ||
| SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine | Q73711457 | ||
| Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand | Q74219879 | ||
| Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid | Q77725799 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 | ||
| CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts | Q30049210 | ||
| Structural determinants for recognition and translocation by the anandamide transporter | Q33861497 | ||
| Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol | Q33902321 | ||
| The endocannabinoid system as a target for therapeutic drugs. | Q33934278 | ||
| N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation | Q34390917 | ||
| Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra | Q34421920 | ||
| Functional role of high-affinity anandamide transport, as revealed by selective inhibition | Q34436019 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| Adverse effects of cannabis | Q34482452 | ||
| Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome | Q34486318 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis | Q34631075 | ||
| Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 | ||
| Control of pain initiation by endogenous cannabinoids. | Q34749934 | ||
| Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells | Q37599138 | ||
| Pharmacology of cannabinoid receptors | Q40437020 | ||
| Psychiatric symptoms in cannabis users | Q40697005 | ||
| The N-acylation-phosphodiesterase pathway and cell signalling | Q41016506 | ||
| Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. | Q41292913 | ||
| Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 | ||
| Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons | Q42450378 | ||
| Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease | Q42464432 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats | Q42536101 | ||
| The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease | Q42546097 | ||
| Endogenous cannabinoid signaling | Q46128123 | ||
| Cannabinoid receptors and immunity | Q48029970 | ||
| Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen | Q48189572 | ||
| Cannabinoid transmission and reward-related events | Q48285165 | ||
| Role of the endogenous cannabinoid system in the regulation of motor activity | Q48285177 | ||
| Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors | Q48290397 | ||
| CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats | Q48327876 | ||
| Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent | Q48332786 | ||
| Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. | Q48452719 | ||
| Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors | Q48518726 | ||
| Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. | Q48631827 | ||
| Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion | Q48653795 | ||
| Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system | Q49060851 | ||
| Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes | Q49065140 | ||
| Substance use disorder and the early course of illness in schizophrenia and affective psychosis. | Q51552241 | ||
| Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. | Q64996366 | ||
| Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey | Q68806311 | ||
| Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists | Q71293074 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | endocannabinoid system | Q368952 |
| P304 | page(s) | 151-158 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Chemistry and Physics of Lipids | Q15746139 |
| P1476 | title | The endocannabinoid system: a physiological perspective on its role in psychomotor control | |
| P478 | volume | 108 |
| Q33759649 | AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking |
| Q24793780 | Anandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamate |
| Q44264995 | Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation |
| Q36977766 | Cannabinoids and neuroprotection in basal ganglia disorders. |
| Q37149113 | Cannabinoids, endocannabinoids, and related analogs in inflammation |
| Q34199483 | Cannabis and the brain |
| Q45138733 | Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. |
| Q44443061 | Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors |
| Q28085390 | Dietary factors in the etiology of Parkinson's disease |
| Q34641465 | Endocannabinoids and cannabinoid receptor genetics |
| Q35025270 | Endocannabinoids and their actions |
| Q46652152 | Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice |
| Q38686274 | Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives |
| Q35035806 | Recent advances in the synthesis of endocannabinoid related ligands |
| Q44241696 | Tricyclic pyrazoles. Part 1: synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1and CB2 cannabinoid receptors. |
| Q51993486 | [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders]. |
Search more.